GlobeNewswire Caladrius Biosciences, Inc. Closes $65 Million Registered Direct Offerings Priced At-The-Market under Nasdaq Rules BASKING RIDGE, N.J., Feb. 17, 2021 (GLOBE NEWSWIRE) — Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to reverse disease, today announced that it has closed on its previously announced sale to institutional investors of an… Source link
Read More »Google will pay News Corp for the right to showcase its news articles
Alphabet CEO Sundar Pichai speaks during a session at the World Economic Forum (WEF) annual meeting in Davos, on January 22, 2020. Fabrice Coffrini | AFP | Getty Images Google struck a deal with the Murdoch family owned media conglomerate News Corp. as proposed legislation in Australia threatens to jeopardize the tech platform’s future operations in the country. Under the three-year deal announced Wednesday, News Corp. brands in the U.S., U.K. and Australia like The Wall Street Journal and New… Source link
Read More »News Corp latest to make deal with Google in Australia push
… Source link
Read More »News Corp. to provide Google News Showcase with premium content as part of 3-year news partnership
News Corp. NWS, -1.16% announced Wednesday a three-year agreement with Alphabet Inc.’s GOOGL, +0.43% Google, in which News Corp. will provide premium content for the Google News Showcase offering in return for “significant payments” from Google. MarketWatch publisher Dow Jones is a division of News Corp. As part of the agreement, News Corp. will provide news from its news sites, including The Wall Street Journal, Barron’s,… Source link
Read More »Zomedica Corp. Increases Previously Announced Bought Deal Offering of Common Shares to $173.5 Million
ANN ARBOR, Mich., Feb. 08, 2021 (GLOBE NEWSWIRE) — Zomedica Corp. (NYSE American: ZOM), (“Zomedica” or the “Company”), a veterinary health company creating point-of-care diagnostics products for dogs and cats, today announced that, due to demand, the underwriter has agreed to increase the size of the previously announced public offering and purchase on a firm commitment basis 91,315,790 common shares of Zomedica, at a price to the public of $1.90 per share, less underwriting… Source link
Read More »